TrialJournal of thrombosis and thrombolysis2018

Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention.

Gerald Chi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.